# Genesis Biomed

Genesis Biomed is a Private Equity based in Barcelona, Spain.

## Overview

- **Organization type:** Private Equity
- **Headquarters:** Barcelona, Spain
- **Region:** Europe
- **Address:** Barcelona, Spain
- **Founded:** 2017
- **Assets under management:** Undisclosed
- **Website:** genesis-biomed.com
- **LinkedIn:** https://www.linkedin.com/company/genesisbiomed

## Regulatory record

- **Reports private funds:** No

## About

GENESIS Biomed is a consultancy firm in the biomedical healthcare sector specialized in providing consulting services in the genesis and first phases of lifecycle of biomedical spin-off and start-up companies, entrepreneurs and research centers. It helps entrepreneurs and researchers shape their business plans and supports them in private fundraising. The company also manages GENESIS Ventures and GENESIS Tech Transfer Boost, two investment vehicles that invest in early-stage biomedical research projects.

## Sectors

- Digital Health
- Healthcare Services

## People

- Josep Lluís Falcó — Founder and CEO
- Natalia de la Figuera — Managing partner and COO
- Jordi Ortiz — Senior Consultant
- Gisela Gallego — Consultant
- Berta Borràs — Consultant
- Mireia Samitier — Consultant
- Anna Miró — Consultant
- Alberto Rodríguez — Consultant trainee
- Mariona Costa — Consultant trainee
- Teresa Bau — Communications Manager

## Questions

### What investment stages does Genesis Biomed target?

Genesis Biomed focuses on early-stage investments, including seed, start-up, and spin-off opportunities. The firm is structured to enter at the point where academic research becomes a commercial venture, providing both capital and company-building support. This narrow stage focus means it does not compete for later-stage growth equity or buyout deals in the life-sciences sector.

### Does Genesis Biomed focus on any specific sub-sectors within healthcare?

The firm's mandate spans biomedical and health-tech ventures broadly, including digital health, medical devices, diagnostics, and therapeutic platforms. Genesis Biomed evaluates opportunities that originate from academic research institutions and require specialized scientific vetting. It does not publicly state any sub-sector exclusions, but its deal flow is naturally shaped by the research strengths of its Southern European network.

### How does Genesis Biomed source its investment opportunities?

Genesis Biomed sources opportunities primarily through its network of research institutions, universities, and teaching hospitals in Spain and across Europe. The firm's Barcelona headquarters places it in a dense biomedical research cluster, giving it proximity to academic spin-offs before they reach broader venture auction processes. This relationship-driven origination model is common among specialized early-stage health-tech funds in Europe.

### What is Genesis Biomed's geographic investment focus?

Genesis Biomed invests primarily in Spain and the broader European market. Its Barcelona headquarters anchors it in one of Southern Europe's most active biomedical research ecosystems, and the firm's deal flow reflects that regional concentration. It has not publicly disclosed any dedicated offices or investment programs outside of Europe.

## Related profiles

- [Genesia Ventures](https://altss.com/profile/genesia-ventures)
- [Genesis Capital](https://altss.com/profile/genesis-capital)

---

Last updated: 2026-08-11T15:06:49.768Z

Canonical page: https://altss.com/profile/genesis-biomed

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology